Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • DISPROPORTIONATE SHARE HOSPITALS—N.D. Tex.: Texas hospital wins challenge to HHS rule affecting Medicare DSH calculations
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)--D.N.J.: Novo Nordisk sues Eli Lilly for false advertising of Lilly drugs Zepbound® and Mounjaro®
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—D. Utah: Xlear’s challenge to FTC ad-substantiation requirement dismissed as unripe
    • CLINICAL RESEARCH—FDA GUIDANCE NOTICES: Cancer Clinical Trial Eligibility Criteria: Laboratory Values; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
    • CLINICAL RESEARCH—FDA GUIDANCE NOTICES: Cancer Clinical Trial Eligibility Criteria: Performance Status; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
    • CLINICAL RESEARCH—FDA GUIDANCE NOTICES: Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
    • COVID-19—10th Cir.: PREP Act immunity shields AstraZeneca from vaccine trial injuries, waiver of immunity remains a question
    • HIPAA—N.D. Cal.: FTC, States Sue Hims & Hers Over Privacy, Consumer Protection Violations
    • MEDICARE OVERPAYMENTS AND UNDERPAYMENTS—N.D. Ohio: Medicare provider’s request for hearing improperly deemed untimely
    • PRODUCTS LIABILITY (DEVICES)—D. Conn.: Court holds Novo Nordisk to one-dispositive-motion rule, denies summary judgment
    • PRODUCTS LIABILITY (DEVICES)—D. Conn.: Novo Nordisk stuck with products liability claims involving insulin pens
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, HIPAA—N.D. Cal.: FTC, States Sue Hims & Hers Over Privacy, Consumer Protection Violations, (Jul 30, 2026)

    Organizations Mentioned:Bureau of Consumer Protection | Snap, Inc. | West Oaks Venture, LLC

    By Tom Leithauser

    Telehealth provider Hims & Hers Health, Inc., violated patients’ privacy by sharing health data with social media platforms despite promising customers it would keep their data private, according to a lawsuit filed today by the Federal Trade C ...

    By Tom Leithauser

    Telehealth provider Hims & Hers Health, Inc., violated patients’ privacy by sharing health data with social media platforms despite promising customers it would keep their data private, according to a lawsuit filed today by the Federal Trade Commission and the states of California and Utah.

    “Despite promising privacy and discretion, Hims shared consumers’ sensitive health information with third-party advertising companies and platforms (‘Advertising Platforms’) such as Meta Platforms, Inc. (‘Meta’) and Snap Inc. (‘Snap’),” according to the complaint filed in the U.S. District Court for the Northern District of California.

    “During this time period, Hims did not clearly and conspicuously disclose to consumers that it would share their health information with Advertising Platforms,” it says.

    The lawsuit alleges violations of the FTC Act, state consumer protection laws, and the Restore Online Shoppers’ Confidence Act, which prohibits deceptive billing and subscription practices.

    “The FTC’s complaint lays out a troubling scenario—consumers unknowingly locked into recurring subscriptions and the disclosure to third parties of consumers’ most private health information without their consent,” Christopher Mufarrige, director of the FTC’s Bureau of Consumer Protection, said in a news release.

    The lawsuit seeks civil penalties and an injunction to prevent future violations.

    Hims & Hers disputed the allegations in the lawsuit, posting on social media that the complaint “disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims.”

    “This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense,” the post added. “We are confident in our position and will vigorously defend ourselves against these baseless claims.”—Tom Leithauser, [email protected]

    Cases: CaseDecisions EHRNews EnforcementNews HIPAANews CaliforniaNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use